Atovaquone in the treatment of Babesia microti infections in hamsters

American Journal of Tropical Medicine and Hygiene

Volumn 55, Issue 2, 1996, Pages 219-222

  Wittner, Murray ^a   Lederman, Jeffrey ^b   Tanowitz, Herbert B ^a   Rosenbaum, Gary S ^c   Weiss, Louis M ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b New Rochelle Radiology Associates   (United States)

^c Southampton Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLINDAMYCIN; QUININE;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ARTICLE; BABESIA MICROTI; BABESIOSIS; CONTROLLED STUDY; DRUG EFFICACY; HAMSTER; NONHUMAN; ORAL DRUG ADMINISTRATION; PARASITE ISOLATION; PARASITEMIA;

ANIMALIA; BABESIA MICROTI; CINCHONA PUBESCENS; CRICETINAE;

EID: 0029756593     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.1996.55.219     Document Type: Article

References (18)

1. Rowin KS, Tanowitz HB, Rubinstein A, Kunkel M, Wittner M. 1985 Babesiosis in asplenic hosts. Trans R Soc Trop Med Hyg 87: 442-444.
2. Wittner M, Rowin KS, Tanowitz HB, Hobbs JF, Saltzman S, Wenz B, Hirsch R, Chisolm E, Healy GR, 1982. Successful chemotherapy of transfusion babesiosis. Ann Intern Med 96: 601-604.
3. Rowin KS, Tanowitz HB, Wittner M, 1982. Therapy of experimental babesiosis. Ann Intern Med 97: 556-558.
4. Herwaldt BL, Springs F, Roberts PP, Eberhard ML, Case K, Persing DH, Agger WA, 1995. Babesiosis in Wisconsin: a potentially fatal disease. Am J Trop Med Hyg 53: 146-151.
5. Falagas ME, Klempner MS, 1996. Babesiosis in AIDS: presentation as fever of unknown origin and chronicity of infection. Clin Infect Dis 22: 809-812.
6. Ong KR, Stravropoulos C, Inada Y, 1990. Babesiosis, asplenia and AIDS. Lancet 336: 112.
7. Hughes WT, Gray VL, Gutteridge WE, Latter VS, Pudney M, 1990. Efficacy of a hydroxynaphthoquinone, 566C80, in experimental Pneumocystis carinii pneumonitis. Antimicrob Agents Chem 34: 225-228.
8. Artymowicz RJ, James VE, 1993. Atovaquone: a new antipneumocystis agent. Clin Pharmacol 12: 563-570.
9. Kovacs JA, 1992. NIAID Clinical Center Intramural AIDS Program. Efficacy of atovaquone in the treatment of toxoplasmosis in patients with AIDS. Lancet 340: 637-638.
10. Fry M, Pudney M, 1992. Site of action of the antimalarial hydroxynaphthoquinone, 2-[trans-4-(4′-chlorophynyl) cyclo]-3-hydroxy-1,4-naphthoquinone (566C80). Biochem Pharmacol 43: 1545-1553.
11. Ittarat I, Asawamahasakda W, Meshnick S, 1994. The effects of antimalarials on the Plasmodium falciparum dihydoorotate dehydrogenase. Exp Parasitol 79: 50-56.
12. Hammond DJ, Burchell JR, Pudney M, 1985. Inhibition of pyrimidine synthesis de novo in Plasmodium falciparum by 2-(4-t-butylcyclohexyl)-3-hydroxy-1,4-naphthoquinone in vitro. Mol Biochem Parasitol 14: 97-108.
13. Hughes WT, Oz HS, 1995. Successful prevention and treatment of babesiosis with atovaquone. J Infect Dis 172: 1042-1046.
14. Weiss LM, Wittner M, Wasserman S, Oz HS, Retsema J, Tanowitz HB, 1993. Efficacy of azithromycin for treating Babesia microti infection in the hamster model. J Infect Dis 168: 1289-1292.
15. Miller LH, Neva FA, Gill F, 1978. Failure of chloroquine in human babesiosis (Babesia microti): case report and chemotherapeutic trials in hamsters. Ann Intern Med 88: 200-202.
16. White NJ, 1994. Artemisinin: current status Trans R Soc Trop Med Hyg 88 (suppl 1): 3-4.
17. Hudson AT, Randall AW, Fry M, Ginger CD, Hill B, Latter VS, McHardy N, Williams RB, 1985. Novel anti-malarial hydroxynaphthoquinones with potent broad spectrum anti-protozoal activity. Parasitology 90: 45-55.
18. Kyle DE, Milhous WK, Rossan RN, 1993. Reversal of Plasmodium falciparum resistance to chloroquine in Panamanian Aotus monkeys. Am J Trop Med Hyg 48: 126-133.